



.-l-l- Slf -l .,*.,ti,).iJs 
-Lrl ,r...,1'.,*.rLS, etL *t: ,Q!
:;t,rc'
U266,s*+ cStaJst- ,-*,rtT (SJr ): 
-,t-*sE 5 rii(11-6a jl .f-l*
cSyL" l;o;:t ,,,3,i
uJU .u-t iS.l :L^i^ll .rl:,,.1
c.,t '..^ | ,j.,..,,.-o ,.lljj .r,-,rG L.ir+ ;r:S.r :;31-,i* +$t-..,1
\ Y12- \ f16,Ji.,:-l Jl--,
\.f :.t(
,/?n,ilt;
Kerman University of Medical Sciences
Faculty of Allied School
In Partial Fulfillment for the Degree Master of Sciences
Title:
Investigation of telomerase inhibition effect on cell apoptosis of











</.{-'/r: tv j 
--.*_
:.:-(>
.ri ,t* frr q d", ! I )r" .," ,_lt* J#t f*." 1r aL>;l ;L;l .Sto..,Ur ,-+.fl f ,lyi; :*,-L.
a,JlJ* 
.yl "-iu .-rti:L .t uLr, ;Lp 6ly. .iy GUf tfr.lt oi;rlr ,li -iu .&'Ly" .Jb -.-
Jl- S 6rs 69; N r" 6) oVtl3..7'SlY ,t111 o.u 
".;i:;:L,_/"U *1; 4..MST-312 ; _- -
.r-:! 
.-r Ul65 _-
pu ,riri, )L; .iL; .sl" ,_:L.j ,r MST-3 12 ,il*- dG j9r L, tJ266 .jl^ J+ :[A sJ9, ,. : .
MTT 
.rp &t ,rrlt 1l o:l,i:.,1 t ..rl u<J9,U. cJLr ,+ rto-r .ft, d. ..,rji t? t" J/- u! 
-r- .-
4;y.i ;:a G,)t,Jlr d,*:3.a .s rl3jl TAAD/ V-.1^J]i t? l{+ ,-t.l st*i.Kt\ )s-.., 
-- 
.
Real-Tirne PCR ,l,, tl ,RNA vl;;,:-l r r.,1. ! 1^ J+ ,-,r,5.rt *';l .r- BCL2 e BAX d-i _ * -
fA o-r, a, MST-3 12 )\ 9"9f- A cLIo ;.: o.r.::, ;Lj .J1^ J/- jL orjl 1.: .,.lat-l I a. ;l 
-.:= ::-- :
a, MST-312 )\ 9"9f*4, f ,Y cJta jer ! t'L fA ,1[q.; ;1 q Ji- .!rb c!t! .-l"i srr -i-
!o;'LfAaa;ly )uU266.rt^J+ i)y.y.ialrsl'1Y.1+-)l,.c,it-.-rblJ'/.rr tri,-: 
---
a, MST-3 12 )\ r"9f- Y d;E ! .rl*" .rl^ J/- ,,L* .r';i o.laL;r MST-312 ;\ 9";;<-
.r,-.:f BCL2 




"r^tt c.9! MST-312 \ ,elr" jby".r1^ J+ r:r" ol,9f ,4 ,sF ++- ;
.r,l44 rL MST-312 aJ u.:.r.,lLij Ls-r" e.\.)r.r Jl-;yly"l..ri-1,p1 l.(Jyl:. *-
..i-;lL a:ilr rr,1ll,-l#L erlr..,L,,) 61y.sl9;.r.9:1lr Ssyi.Jl^ J/- );. j:
;rqr'i ,MSt-312,t et- 
-t.;* , .
Abstract
Investigation of telomerase inhibition effect on cell apoptosis of multiple myeloma cell line
u266
Introduction: Telomerase-targeted therapy for cancer has received great attention because
telomerase is expressed in almost alI cancer cells but is inactive in most normal somatic cells. This
study was aimed to investigate the effects of telomerase inhibitor MST-3 12, a chemically modified
derivative of epigallocatechin gallate (EGCG), on Multiple Myeloma cell line U266.
Materials and methods: U266 cells were treated with different concentration of MST-312 in
different times, and then cell viability by trlpan blue exclusion assay, metabolic activity by MTT
assay, and Apoptosis by Annexin V Apoptosis Detection Kit were measured. To funher investigate
apoptosis, BAX and BCL2 gene expression of the treated celis was investigated by RNA extraction
and quantitative Real-Time PCR.
Results: MST-3 12 exerted a dose-dependent short-term cl.totoxic effect on Multiple Myeloma
cells. Over 50 9/o decrease in the viabiliry of treated cells was seen in 8 pM concentration oIMST-
312 within 48 h. The cytotoxic effect of MST-3 12 was concentration-dependent, ,,vith
approximately 8,25,46, and 62o/o reduction in metabolic activity after 48 h exposure to 0,2,4,
and 8 prM of MST-3 12, respectively. Gene expression analysis showed downregulation of
antiapoptotic gene Bc[-2, and upregulation of apoptotic gene BAX. Importantly, MST-3 l2 didnot
show any apoptotic eftect in normal human peripheral blood mononuclear cells (PBMCs).
Discussion and conclusion: Inhibition of telomerase activity by MST-3 l2 represents a novel
ireatment strategy for Multiple Myeloma cancer.
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